Team management and anticoagulation treatment for amniotic fluid embolism-the current viewpoint
CHEN Dun-jin
CHEN Yan-hong
Abstract：Amniotic fluid embolism (AFE) is one of the catastrophic complications of pregnancy,and it is often life-threatening to pregnant women and fetus.Although the cause is clear,but the exact mechanisms of AFE are still unclear.The use of anticoagulant in AFE therapy remains controversial when disseminated intravascular coagulation (DIC)occurs.AFE is often with acute onset and develops rapidly,so it's hard to select the best time to use anticoagulant,and improper use of anticoagulant may aggravate the disease.So,anticoagulant isn't recommended for routine use in clinics.Based on the treatment experience and lessons of AFE at home and abroad,early recognition and a rapid response team are the key to successful treatment of AFE.
Keywords：amniotic fluid embolismdisseminated intravascular coagulationanticoagulantsrapid response team
Publication Date：2017-01-01
Online Publishing Date：2025-08-15(First online date of this platform, not the publication date of the document)
Pages：4( 691-694 )